glp 1 neurological effects Frontiers Beyond diabetes and obesity: GLP‐1

Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, et al

The 4 mg and 8 mg groups showed very similar results at 24 weeks, suggesting that moderate doses can produce excellent outcomes

"The longer patients were exposed to these medications, the greater their risk appeared to be." In about two out of every 10 cases, dry AMD develops into wet AMD also known as neovascular age-related macular degeneration (nAMD)

Unfortunately, nursing home abuse and neglect can occur, leaving residents at risk and vulnerable

SGLT2 inhibitors appear more effective in mitigating glomerular hyperfiltration and lowering heart failure risk, whereas GLP-1 receptor agonists are particularly beneficial in reducing albuminuria and atherosclerotic cardiovascular events